1. Home
  2. NERV vs ANGI Comparison

NERV vs ANGI Comparison

Compare NERV & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$5.04

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$6.10

Market Cap

233.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NERV
ANGI
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
210.1M
233.4M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
NERV
ANGI
Price
$5.04
$6.10
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$10.50
$17.00
AVG Volume (30 Days)
334.2K
1.0M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1242.86
EPS
N/A
N/A
Revenue
$41,175,600.00
$736,386,000.00
Revenue This Year
N/A
$3.25
Revenue Next Year
N/A
$3.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.60
52 Week Low
$1.63
$4.53
52 Week High
$12.46
$19.42

Technical Indicators

Market Signals
Indicator
NERV
ANGI
Relative Strength Index (RSI) 53.71 56.36
Support Level $5.02 $4.67
Resistance Level $5.61 $6.62
Average True Range (ATR) 0.47 0.41
MACD 0.14 0.12
Stochastic Oscillator 59.78 90.60

Price Performance

Historical Comparison
NERV
ANGI

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

Share on Social Networks: